Iatrogenic Transmission of Alzheimer’s through Bone Marrow

Conclusive demonstration of iatrogenic Alzheimer’s disease transmission in a model of stem cell transplantation
From researchers at the University of British Columbia: “Through adoptive transplantation of donor bone marrow stem cells carrying a mutant human amyloid precursor protein (APP) transgene into either APP-deficient knockout or normal recipient animals, we observed rapid development of AD pathological hallmarks. These pathological features were significantly accelerated and emerged within 6–9 months post transplantation and included compromised blood-brain barrier integrity, heightened cerebral vascular neoangiogenesis, elevated brain-associated β-amyloid levels, and cognitive impairment. Furthermore, our findings underscore the contribution of β-amyloid burden originating outside of the central nervous system to AD pathogenesis within the brain.” MORE
Image Credit: ScienceDirect